Back to company

CONRIG PHARMA ApS: Financial statements 2017

CVR: 33373236

CONRIG PHARMA ApS (CVR 33373236) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -304,565 and a net result of DKK -286,337 compared with DKK -530,670 the year before. Equity amounted to DKK -196,540.

Gross Profit
-304,565 kr.
Profit/Loss
-286,337 kr.
Equity
-196,540 kr.
Total Assets
138,657 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017--305 t.-286 t.-197 t.-
2016--684 t.-531 t.90 t.-
2015--89 t.-74 t.620 t.-
2014--93 t.-81 t.94 t.-
2013--228 t.-274 t.276 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like CONRIG PHARMA ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2017

CONRIG PHARMA ApS: The 2016 annual report is outMay 29, 2017

CONRIG PHARMA ApS has published its annual report for 2016. Gross profit came to DKK -683,941, and the net result was DKK -530,670.

About CONRIG PHARMA ApS

CONRIG PHARMA ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Snickar Karl Johan Tobieson and Lars Christer Fredrik Fåhraeus. The company is owned by Melius Pharma AB. The company has 0 employees. In 2025, the company reported a gross profit of DKK -98,936 and a net result of DKK -95,786 compared with DKK -100,217 the year before. Equity amounted to DKK 0.